He is correct to point out that all of the companies are continuing negotiations -- since in most cases, the federal government is the largest single buyer of any given medication on the list of ten. No matter how you slice it, this will be a benefit to people of limited means who need the meds, just to survive. Here's the latest:
. . .All of the manufacturers whose drugs were chosen for the federal government’s Medicare price negotiation program have sent back counteroffers for what they consider to be a maximum fair price, the White House said Monday.
President Biden confirmed in a statement Monday that all companies are continuing to engage in the negotiation process, despite the host of legal battles brought by a few, to block the program. . . .
Talks are expected to go through Aug. 1, when negotiations officially end, per CMS guidance. The maximum fair prices are scheduled to be published Sept. 1 and are set to go into effect at the start of 2026. . . .
As we indicated repeatedly here, there is no constitutional problem with saying a manufacturer must at least negotiate in good faith. And the IRA contemplates that no manufacturer must sell at any specific price to the government. So this will, like the ACA of 2010. . . pass muster in the Supremes, in my experienced opinion. Onward.
नमस्ते
No comments:
Post a Comment